Zhengping Feng

577 total citations
18 papers, 199 citations indexed

About

Zhengping Feng is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Zhengping Feng has authored 18 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Zhengping Feng's work include Hormonal Regulation and Hypertension (5 papers), Adrenal and Paraganglionic Tumors (5 papers) and Adrenal Hormones and Disorders (3 papers). Zhengping Feng is often cited by papers focused on Hormonal Regulation and Hypertension (5 papers), Adrenal and Paraganglionic Tumors (5 papers) and Adrenal Hormones and Disorders (3 papers). Zhengping Feng collaborates with scholars based in China and Australia. Zhengping Feng's co-authors include Xiaoju Wang, Jiling Li, Lixue Chen, Weixue Tang, Qifu Li, Hua Qu, Pei Zhang, Qing Zhou, Jinbo Hu and Jing Liao and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Hypertension and Molecular and Cellular Endocrinology.

In The Last Decade

Zhengping Feng

16 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengping Feng China 8 79 73 68 36 29 18 199
Fusheng Fang China 11 109 1.4× 100 1.4× 56 0.8× 30 0.8× 44 1.5× 45 309
G Belsanti Italy 4 89 1.1× 135 1.8× 39 0.6× 27 0.8× 40 1.4× 4 309
Laura G.M. Janssen Netherlands 9 104 1.3× 56 0.8× 47 0.7× 43 1.2× 87 3.0× 15 271
Maki Yokomoto‐Umakoshi Japan 13 149 1.9× 70 1.0× 105 1.5× 16 0.4× 34 1.2× 33 303
Sylwia Górczyńska-Kosiorz Poland 11 73 0.9× 96 1.3× 150 2.2× 16 0.4× 33 1.1× 36 295
Diego Bailetti Italy 10 95 1.2× 55 0.8× 54 0.8× 92 2.6× 25 0.9× 20 229
Biying Meng China 9 31 0.4× 93 1.3× 41 0.6× 46 1.3× 25 0.9× 9 230
Yunting Zhou China 11 68 0.9× 131 1.8× 117 1.7× 22 0.6× 33 1.1× 34 303
Cuixia Gao China 11 153 1.9× 152 2.1× 35 0.5× 35 1.0× 19 0.7× 19 362
Sinan Tanyolaç Türkiye 7 100 1.3× 97 1.3× 45 0.7× 48 1.3× 39 1.3× 11 264

Countries citing papers authored by Zhengping Feng

Since Specialization
Citations

This map shows the geographic impact of Zhengping Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengping Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengping Feng more than expected).

Fields of papers citing papers by Zhengping Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengping Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengping Feng. The network helps show where Zhengping Feng may publish in the future.

Co-authorship network of co-authors of Zhengping Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengping Feng. A scholar is included among the top collaborators of Zhengping Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengping Feng. Zhengping Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zheng, Yang, et al.. (2024). A New Quantitative Neuropad for Early Diagnosis of Diabetic Peripheral Neuropathy. Diabetes/Metabolism Research and Reviews. 40(8). e70010–e70010.
2.
Hu, Jinbo, Hang Shen, Aipin Zhang, et al.. (2024). Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET/CT for the Classification of Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 110(8). e2583–e2590. 5 indexed citations
3.
Feng, Zhengping, et al.. (2023). The Ca∗Cl/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism. Endocrine Practice. 30(3). 231–238. 2 indexed citations
4.
Song, Ying, Jun Yang, Hang Shen, et al.. (2022). Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism. Journal of Hypertension. 40(9). 1692–1701. 5 indexed citations
5.
Zhang, Pei, Jing Liao, Xiaoju Wang, & Zhengping Feng. (2020). High glucose promotes apoptosis and autophagy of MC3T3-E1 osteoblasts. Archives of Medical Science. 19(1). 138–150. 17 indexed citations
6.
Wang, Hongman, Ying Song, Zhixin Xu, et al.. (2020). Abnormal Dexamethasone Suppression Tests in a Rifapentine-Treated Patient With Primary Aldosteronism. Frontiers in Endocrinology. 11. 593–593. 1 indexed citations
7.
Hu, Jinbo, Ying Song, Wenwen He, et al.. (2020). Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study. Endocrine Practice. 27(4). 326–333. 15 indexed citations
8.
Wang, Kanran, Jinbo Hu, Jun Yang, et al.. (2020). Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 105(7). e2449–e2456. 28 indexed citations
9.
Wu, Rui, Yao Ding, Qing Zhou, et al.. (2018). Relation of plasma galectin-3 level with parameters of chronic inflammation and insulin resistance in the patients with polycystic ovary syndrome. Zhonghua neifenmi daixie zazhi. 34(7). 578–582. 1 indexed citations
10.
Zhou, Qing, Qian Ge, Yao Ding, et al.. (2018). Relationship between serum adipsin and the first phase of glucose‐stimulated insulin secretion in individuals with different glucose tolerance. Journal of Diabetes Investigation. 9(5). 1128–1134. 37 indexed citations
11.
Feng, Zhengping, et al.. (2016). Relationship between serum 25-(OH) D level and body fat distribution in patients with type 2 diabetes. 22(1). 56–60.
12.
Liu, Dan, Hua Qu, Hang Wang, et al.. (2016). Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion. Obesity Research & Clinical Practice. 12(1). 9–15. 10 indexed citations
13.
Li, Jiling, et al.. (2016). MicroRNA-335-5p inhibits osteoblast apoptosis induced by high glucose. Molecular Medicine Reports. 13(5). 4108–4112. 17 indexed citations
14.
Wang, Xiaoju, Zhengping Feng, Jiling Li, Lixue Chen, & Weixue Tang. (2016). High glucose induces autophagy of MC3T3-E1 cells via ROS-AKT-mTOR axis. Molecular and Cellular Endocrinology. 429. 62–72. 35 indexed citations
17.
Feng, Zhengping, Xiaoyu Li, Rong Jiang, et al.. (2013). Associations of SAA1 gene polymorphism with Lipid lelvels and osteoporosis in Chinese women. Lipids in Health and Disease. 12(1). 39–39. 11 indexed citations
18.
Feng, Zhengping, et al.. (2011). Lentiviral-mediated RNAi targeting p38MAPK ameliorates high glucose-induced apoptosis in osteoblast MC3T3-E1 cell line.. PubMed. 49(2). 94–104. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026